FESCA holds event in EU Parliament
To celebrate World Scleroderma Day 2015, the Federation of European Scleroderma Associations (FESCA aisbl.) held the European Parliamentary event “Unveiling Scleroderma: Hidden Truth” on June 30 in Brussels. All MEPs were invited to this EU Parliament meeting to listen as the invited experts spoke about the quality of care available for scleroderma patients across Europe.
Hosted by James Carver MEP, who lost his wife to scleroderma in 2009, the event provided a unique forum for patients, physicians, and politicians to share their stories and understanding.
Key medical professionals from across Europe highlighted the importance of early diagnosis, sufficient investment in research and specialist centres, and equity of care. The presentations on these topics included insightful talks from Professor Denton (UK), Professor Distler (Switzerland), Dr. Posada De la Paz (Spain) and Professor Van den Hoogen (Netherlands). These key rheumatologists spoke of how although the effects of scleroderma can be devastating, proper treatment and management will enable people with scleroderma can lead full and rewarding lives.
The MEPs attending were also privileged to hear from a number of patients themselves, from Denmark, the Netherlands, Hungary and the UK, who shared with the audience inspiring stories of their difficult journeys with scleroderma. EULAR representative Nele Caeyers spoke of the support that is given to FESCA by the EU’s major rheumatology organisation.
World Scleroderma Day 2015 was developed by FESCA to raise awareness of the 2.5 million people currently diagnosed worldwide who live with this rare and under-recognised disease. Its success is due to the commitment of all the national patient support and advocacy groups who form part of the umbrella organisation.
Ann Tyrrell Kennedy, President of FESCA, said “World Scleroderma Day was a huge success and it has been encouraging to see awareness of scleroderma gaining momentum across Europe. It’s so important that we make the journey to a diagnosis as short as possible, and having the support of politicians and physicians alongside patient groups is a really important step to improving millions of lives across the world.”
For more information please contact FESCA
Watch the event on Youtube
news & events
Watch our highlights video showing some of our great achievements in 2022.
Are you living with diffuse scleroderma?
Would you like to be involved in a clinical study testing a new investigational drug for use in Diffuse Scleroderma?
If so, you may be eligible to take part in the DECODE Scleroderma Study
FESCA is proud to be a partner of a the new This is Living campaign launched last month by Boehringer Ingelheim.